Adjuvant sunitinib for high-risk-resected renal cell carcinoma: a meta-analysis of ASSURE and S-TRAC trials

被引:13
|
作者
Gyawali, B. [1 ]
Ando, Y. [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
关键词
D O I
10.1093/annonc/mdw667
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:898 / 899
页数:2
相关论文
共 50 条
  • [41] SYSTEMATIC REVIEW AND META-ANALYSIS OF ADJUVANT THERAPY AFTER NEPHRECTOMY FOR HIGH-RISK, NON-METASTATIC RENAL CELL CARCINOMA
    Bandini, Marco
    Capitanio, Umberto
    Smith, Ariane
    Nazani, Sebastiano
    Marchioni, Michele
    Preisser, Felix
    Mazzone, Elio
    Bondarenko, Helen
    Bravi, Carlo
    Tian, Zhe
    Montorsi, Francesco
    Shariat, Shahrokh
    Kapoor, Anil
    Briganti, Alberto
    Karakiewicz, Pierre
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1070 - E1071
  • [42] Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers
    Ma, Wen-Jie
    Jin, Yan-Wen
    Wu, Zhen-Ru
    Yang, Qin
    Wang, Jun-Ke
    Liu, Fei
    Shi, Yu-Jun
    Li, Quan-Sheng
    Cheng, Nan-Sheng
    HPB, 2020, 22 (07) : 939 - 949
  • [43] Cruciferous Vegetables Consumption and Risk of Renal Cell Carcinoma: A Meta-Analysis
    Liu, Ben
    Mao, Qiqi
    Wang, Xiao
    Zhou, Feng
    Luo, Jindan
    Wang, Chaojun
    Lin, Yiwei
    Zheng, Xiangyi
    Xie, Liping
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2013, 65 (05): : 668 - 676
  • [44] Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis
    Bellocco, R.
    Pasquali, E.
    Rota, M.
    Bagnardi, V.
    Tramacere, I.
    Scotti, L.
    Pelucchi, C.
    Boffetta, P.
    Corrao, G.
    La Vecchia, C.
    ANNALS OF ONCOLOGY, 2012, 23 (09) : 2235 - 2244
  • [45] Vitamin C intake and risk of renal cell carcinoma: a meta-analysis
    Jia, Li
    Jia, Qingling
    Shang, Yonggang
    Dong, Xingyou
    Li, Longkun
    SCIENTIFIC REPORTS, 2015, 5
  • [46] Vitamin C intake and risk of renal cell carcinoma: a meta-analysis
    Li Jia
    Qingling Jia
    Yonggang Shang
    Xingyou Dong
    Longkun Li
    Scientific Reports, 5
  • [47] ADJUVANT THERAPY AFTER SURGERY IN RENAL CELL CARCINOMA: SYSTEMATIC REVIEW WITH META-ANALYSIS
    Reis, Leonardo O., Sr.
    Scherr, A. J. O.
    Sasse, E. C.
    Lima, C. S. P.
    Lima, J. P.
    Sasse, A. D.
    Ferreira, Ubirajara, Sr.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 501 - 502
  • [48] Adjuvant therapy for locally advanced renal cell carcinoma: A meta-analysis and systematic review
    Bai, Yangyang
    Li, Songchao
    Jia, Zhankui
    Ding, Yinghui
    Gu, Chaohui
    Yang, Jinjian
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (02) : 79.e1 - 79.e10
  • [49] Phase 3 trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: exploratory molecular analysis of tumor biomarkers
    George, Daniel J.
    Martini, Jean-Francois
    Chang, Yen-Hwa
    Staehler, Michael
    Breza, Jan
    Patard, Jean-Jacques
    Motzer, Robert J.
    Magheli, Ahmed
    Escudier, Bernard
    Carteni, Giacomo
    Gerletti, Paola
    Li, Sherry
    Casey, Michelle
    Laguerre, Brigitte
    Pandha, Hardev S.
    Pantuck, Allan J.
    Patel, Anup
    Lechuga, Maria
    Ravaud, Alain
    CANCER RESEARCH, 2017, 77
  • [50] Risk of Hand-Foot Skin Reaction with the Multitargeted Kinase Inhibitor Sunitinib in Patients with Renal Cell and Non-Renal Cell Carcinoma: A Meta-analysis
    Chu, David
    Lacouture, Mario E.
    Weiner, Elizabeth
    Wu, Shenhong
    CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 11 - 19